Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary CirrhosisInterventions: Drug: Fenofibrate; Drug: UDCASponsor: Xijing Hospital of Digestive DiseasesRecruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2016 Category: Research Source Type: clinical trials

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary CirrhosisInterventions: Drug: Fenofibrate; Drug: UDCASponsor: Xijing Hospital of Digestive DiseasesRecruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2016 Category: Research Source Type: clinical trials

Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis Interventions: Drug: Fuzhenghuayu; Drug: UDCA Sponsor: Xijing Hospital of Digestive Diseases Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2016 Category: Research Source Type: clinical trials

Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis (PBC)Interventions: Drug: Placebo Comparator; Drug: Experimental: MBX-8025 50 mg; Drug: Experimental: MBX-8025 200 mgSponsors: CymaBay Therapeutics, Inc.; PRA Health SciencesRecruiting - verified November 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2015 Category: Research Source Type: clinical trials